Skip to main content
SpringerLink
Log in

Adiponectin and Cardiovascular Disease

  • Chapter
Book cover Cardiovascular Endocrinology

Part of the book series: Contemporary Endocrinology ((COE))

References

Adiponectin, an adipocytokine secreted by adipose tissue, enhances insulin sensitivity and inhibits vascular inflammation. Hypoadiponectinemia is associated with endothelial dysfunction, hypertension, coronary heart disease, and other cardiovascular complications. Furthermore, enhancing adiponectin concentrations by lifestyle changes or pharmacological therapy can have cardiovascular-protective effects. In this chapter, we review the association between adiponectin and cardiovascular disease and discuss treatment strategies to ameliorate hypoadiponectinemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 106: 473–481, 2000.

    Article  PubMed  CAS  Google Scholar 

  2. Bajaj M, Ben-Yehuda O: A big fat wedding: association of adiponectin with coronary vascular lesions: J Am Coll Cardiol 48: 1163–165, 2006.

    Article  PubMed  Google Scholar 

  3. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Diabetes Med 15: 539–553, 1998.

    Article  CAS  Google Scholar 

  4. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595–1607, 1988.

    Google Scholar 

  5. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746–26749, 1995.

    Article  PubMed  CAS  Google Scholar 

  6. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript). Biochem Biophys Res Commun 221: 286–289, 1996.

    Article  PubMed  CAS  Google Scholar 

  7. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M: Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 120: 803–812, 1996.

    CAS  Google Scholar 

  8. Shapiro L, Scherer PE: The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 8: 335–338, 1998.

    Article  PubMed  CAS  Google Scholar 

  9. Crouch E, Persson A, Chang D, Heuser J: Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem 269:17311–17319, 1994.

    PubMed  CAS  Google Scholar 

  10. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT: Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55: 249–259, 2006.

    Article  PubMed  CAS  Google Scholar 

  11. Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA: Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89: 200–206, 2004.

    Article  PubMed  CAS  Google Scholar 

  12. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941–946, 2001.

    Article  PubMed  CAS  Google Scholar 

  13. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762–769, 2003.

    Article  PubMed  CAS  Google Scholar 

  14. Chinetti G, Zawadski C, Fruchart JC, Staels B: Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem Biophys Res Commun 14: 151–158, 2004.

    Article  Google Scholar 

  15. Civitarese AE, Jenkinson CP, Richardson D, Bajaj M, Cusi K, Kashyap S, Berria R, Belfort R, DeFronzo RA, Mandarino LJ, Ravussin E: Adiponectin receptor gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of diabetes. Diabetologia 47: 816–820, 2004.

    Article  PubMed  CAS  Google Scholar 

  16. Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA: Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 54: 3148–3153, 2005.

    Article  PubMed  CAS  Google Scholar 

  17. Danforth E: Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26: 1, 2000.

    Article  Google Scholar 

  18. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930–1935, 2001.

    Article  PubMed  CAS  Google Scholar 

  19. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, Smith C: Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88: 960–966, 1991.

    Article  PubMed  CAS  Google Scholar 

  20. Thiebaud D, DeFronzo RA, Jacot E, Golay A, Acheson K, Maeder E, Jequier E, Felber JP: Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism 31: 1128–1236, 1982.

    Article  PubMed  CAS  Google Scholar 

  21. Chen X, Iqbal N, Boden G: The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365–372, 1999.

    Article  PubMed  CAS  Google Scholar 

  22. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K: A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52: 2461–2474, 2003.

    Article  PubMed  CAS  Google Scholar 

  23. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79–83, 1999.

    Article  PubMed  CAS  Google Scholar 

  24. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87: 2764–2769, 2002.

    Article  PubMed  CAS  Google Scholar 

  25. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM: The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51: 2968–2974, 2002.

    Article  PubMed  CAS  Google Scholar 

  26. Hu E, Liang P, Spiegelman BM: AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697–10703, 1996.

    Article  PubMed  CAS  Google Scholar 

  27. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288–1295, 2002.

    Article  PubMed  CAS  Google Scholar 

  28. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277: 25863–25866, 2002.

    Article  PubMed  CAS  Google Scholar 

  29. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, Nawrocki AR, Rajala MW, Parlow AF, Cheeseboro L, Ding YY, Russell RG, Lindemann D, Hartley A, Baker GR, Obici S, Deshaies Y, Ludgate M, Rossetti L, Scherer PE: A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145: 367–383, 2004.

    Article  PubMed  CAS  Google Scholar 

  30. Kim J, Montagnani M, Koh KK, Quon MJ: Reciprocal relationships between insulin resistance and endothelial dysfunction. Circulation113: 1888–1904, 2006.

    Article  PubMed  Google Scholar 

  31. de Winther MP, Kanters E, Kraal G, Hofker MH: Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25: 904–914, 2005.

    Article  PubMed  Google Scholar 

  32. Vincent MA, Montagnani M, Quon MJ: Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium, Curr Diab Rep 3: 279–288, 2003.

    Article  PubMed  Google Scholar 

  33. Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB, Wilson PWF: C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study, Circulation 110: 380–385, 2004.

    Article  PubMed  CAS  Google Scholar 

  34. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO: Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 95: 1747–1755, 1995.

    Article  PubMed  CAS  Google Scholar 

  35. Boger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frolich JC: Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95: 2068–2074, 1997.

    PubMed  CAS  Google Scholar 

  36. Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagarentani H, Kumada M, Ohashi K, Okamoto Y, Nishizawa H, Kishida K; Maeda N; Nagasawa A, Kobayashi H, Hiraoka H, Komai N, Kaibe M, Rakugi H, Ogihara T, Matsuzaw Y: Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42: 231–234, 2003.

    Article  PubMed  CAS  Google Scholar 

  37. Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, Lam KS: Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89: 765–769, 2004.

    Article  PubMed  CAS  Google Scholar 

  38. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278: 45021–45026, 2003.

    Article  PubMed  CAS  Google Scholar 

  39. Hattori Y, Suzuki M, Hattori S, Kasai K: Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 46: 1543–1549, 2003.

    Article  PubMed  CAS  Google Scholar 

  40. Hattori S, Hattori Y, Kasai K: Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats. Metabolism 54: 482–487, 2005.

    Article  PubMed  CAS  Google Scholar 

  41. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102: 1296–1301, 2000.

    PubMed  CAS  Google Scholar 

  42. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103: 1057–1063, 2001.

    PubMed  CAS  Google Scholar 

  43. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100: 2473–2476, 1999.

    PubMed  CAS  Google Scholar 

  44. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, Mohlig M, Pfeiffer AF, Luft FC, Sharma AM: Association between adiponectin and mediators of inflammation in obese women. Diabetes 52: 942–947, 2003.

    Article  PubMed  CAS  Google Scholar 

  45. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H: Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323: 630–635, 2004.

    Article  PubMed  CAS  Google Scholar 

  46. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105: 2893–2898, 2002.

    Article  PubMed  CAS  Google Scholar 

  47. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial, JAMA 289: 1799–1804, 2003.

    Article  PubMed  CAS  Google Scholar 

  48. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K, Nishizawa H, Maeda N, Kobayashi H, Hiraoka H, Matsuzawa Y: Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue, Circulation 107: 671–674, 2003.

    Article  PubMed  CAS  Google Scholar 

  49. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K: Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11: 1096–1103, 2005.

    Article  PubMed  CAS  Google Scholar 

  50. Fujioka D, Kawabata KI, Saito Y, Kobayashi T, Nakamura T, Kodama Y, Takano H, Obata JE, Kitta Y, Umetani K, Kugiyama K: Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol 290:H2409–H2416, 2006.

    Article  PubMed  CAS  Google Scholar 

  51. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23: 85–89, 2003.

    Article  PubMed  CAS  Google Scholar 

  52. Rothenbacher D, Brenner H, Mörz W and Koenig W: Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers, Eur Heart J 26: 1640–1646, 2005.

    Article  PubMed  CAS  Google Scholar 

  53. Kojima S, Funahashi T, Sakamoto T, Miyamoto S, Soejima H, Hokamaki J, Kajiwara I, Sugiyama S, Yoshimura M, Fujimoto K, Miyao Y, Suefuji H, Kitagawa A, Ouchi N, Kihara S, Matsuzawa Y, Ogawa H: The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 89: 667, 2003.

    Google Scholar 

  54. Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB: Adiponectin and future coronary heart disease events among men with type 2 diabetes, Diabetes 54: 534–539, 2005.

    Article  PubMed  CAS  Google Scholar 

  55. Lindsay RS, Resnick HE, Zhu J, Tun ML, Howard BV, Zhang Y, Yeh J, Best LG: Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol 25: e15–e16, 2005.

    Article  PubMed  CAS  Google Scholar 

  56. Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson JE, Ehrlich J, Eckel RH, Rewers M: Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111: 747–753, 2005.

    Article  PubMed  CAS  Google Scholar 

  57. Otsuka F, Sugiyama S, Kojima S, Maruyoshi H, Funahashi T, Matsui K, Sakamoto T, Yoshimura M, Kimura K, Umemura S, Ogawa H: Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 48: 1155–1162, 2006.

    Article  PubMed  CAS  Google Scholar 

  58. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Lowel H: Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol 48: 1369–1377, 2006.

    Article  PubMed  CAS  Google Scholar 

  59. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359: 2140–2144, 2002.

    Article  PubMed  CAS  Google Scholar 

  60. Hashimoto K, Ikewaki K, Yagi H, Nagasawa H, Imamoto S, Shibata T, Mochizuki S: Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care 28: 1182–1186, 2005.

    Article  PubMed  Google Scholar 

  61. Shioji K, Moriwaki S, Takeuchi Y, Uegaito T, Mutsuo S, Matsuda M: Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary intervention. Circ J 71: 675–680, 2007.

    Article  PubMed  CAS  Google Scholar 

  62. Wolk R, Berger P, Lennon RJ, Brilakis ES, Davison DE, Somers VK: Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J 28: 292–298, 2007.

    Article  PubMed  CAS  Google Scholar 

  63. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730–1737, 2004.

    Article  PubMed  CAS  Google Scholar 

  64. Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD: Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 27: 2300–2309, 2006.

    Article  PubMed  CAS  Google Scholar 

  65. Pilz S, Mangge H, Wellnitz B, Seelhorst U, Winkelmann BR, Tiran B, Boehm BO, Marz W: Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metaboli 91: 4277–4286, 2006.

    Article  CAS  Google Scholar 

  66. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, Nesto RW, Wilson PW, Vasan R: Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107: 448-454, 2003.

    Article  PubMed  CAS  Google Scholar 

  67. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS: Obesity and the risk of heart failure. N Eng J Med 347: 305–313, 2002.

    Article  Google Scholar 

  68. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH: Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci 97: 1784–1789, 2000.

    Article  PubMed  CAS  Google Scholar 

  69. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K: Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10: 1384–1389, 2004.

    Article  PubMed  CAS  Google Scholar 

  70. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P: Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112: 1756–1762, 2005.

    Article  PubMed  CAS  Google Scholar 

  71. Nakamura T, Funayama H, Kubo N, Yasu T, Kawakami M, Saito M, Momomura S, Ishikawa SE: Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circulation J 70: 1557–1562, 2006.

    Article  Google Scholar 

  72. George J, Patal S, Wexler D, Sharabi Y, Peleg E, Kamari Y, Grossman E, Sheps D, Keren G, Roth A: Circulating adiponectin concentrations in patients with congestive heart failure. Heart 92: 1420–1424, 2006.

    Article  PubMed  CAS  Google Scholar 

  73. Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T, Sumitsuji S, Kawamoto T, Matsumoto S, Nagaretani H, Kumada M, Okamoto Y, Nishizawa H, Kishida K, Maeda N, Hiraoka H, Iwashima Y, Ishikawa K, Ohishi M, Katsuya T, Rakugi H, Ogihara T, Matsuzawa Y: Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 43: 1195–1200, 2004.

    Article  PubMed  CAS  Google Scholar 

  74. Jung CH, Rhee EJ, Kim SY, Shin HS, Kim BJ, Sung KC, Kim BS, Lee WY, Kang JH, Oh KW, Lee MH, Kim SW, Park JR: Associations between two single nucleotide polymorphisms of adiponectin gene and coronary artery diseases. Endocr J 53: 671–677, 2006.

    Article  PubMed  CAS  Google Scholar 

  75. Lacquemant C, Froguel P, Lobbens S, Izzo P, Dina C, Ruiz J: The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 21: 776–781, 2004.

    Article  PubMed  CAS  Google Scholar 

  76. Hoefle G, Muendlein A, Saely CH, Risch L, Rein P, Koch L, Schmid F, Aczel S, Marte T, Langer P, Drexel H: The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men. Thromb Haemost 97: 451–457, 2007.

    PubMed  CAS  Google Scholar 

  77. Filippi E, Sentinelli F, Romeo S, Arca M, Berni A, Tiberti C, Verrienti A, Fanelli M, Fallarino M, Sorropago G, Baroni MG: The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age <or=50 years). J Mol Med 83: 711–719, 2005.

    Article  PubMed  CAS  Google Scholar 

  78. Bacci S, Menzaghi C, Ercolino T, Ma X, Rauseo A, Salvemini L, Vigna C, Fanelli R, Di Mario U, Doria A, Trischitta V: The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 27: 2015–2020, 2004.

    Article  PubMed  CAS  Google Scholar 

  79. Qi L, Li T, Rimm E, Zhang C, Rifai N, Hunter D, Doria A, Hu FB: The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 54: 1607–1610, 2005.

    Article  PubMed  CAS  Google Scholar 

  80. Nagasawa A, Fukui K, Funahashi T, Maeda N, Shimomura I, Kihara S, Waki M, Takamatsu K, Matsuzawa Y: Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Horm Metab Res 34: 635–639, 2002.

    Article  PubMed  CAS  Google Scholar 

  81. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, Ruzickova J, Kopecky J: Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49: 394–397, 2006.

    Article  PubMed  CAS  Google Scholar 

  82. Neschen S, Morino K, Rossbacher JC, Pongratz RL, Cline GW, Sono S, Gillum M, Shulman GI: Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes 55: 924–928, 2006.

    Article  PubMed  CAS  Google Scholar 

  83. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients, Arterioscler Thromb Vasc Biol 20: 1595–1599, 2000.

    PubMed  CAS  Google Scholar 

  84. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin, Circ Res 94:e27–e31, 2004.

    Article  PubMed  CAS  Google Scholar 

  85. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86: 3815–3819, 2001.

    Article  PubMed  CAS  Google Scholar 

  86. Miyazaki T, Shimada T, Mokuno H, Daida H: Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease, Heart 89: 663, 2003.

    Article  PubMed  CAS  Google Scholar 

  87. Imatoh T, Miyazaki M, Kadowaki K, Babazono A, Sato M, Une H Interaction of low serum adiponectin levels and smoking on coronary stenosis in Japanese men. Int J Cardiol 110: 251–255, 2006.

    Article  PubMed  Google Scholar 

  88. Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, Ouchi N, Ohashi K, Kihara S, Funahashi T, Rakugi H, Ogihara T: Association of hypoadiponectinemia with smoking habit in men, Hypertension 45: 1094–1100, 2006.

    Article  Google Scholar 

  89. Hallakou S, Foufelle F, Doare L, Kergoat M, Ferre P: Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 46: 1393–1399, 1997.

    Article  PubMed  CAS  Google Scholar 

  90. Gurnell M, Wentworth JM, Agostini M, Adams M, Collingwood TN, Provenzano C, Browne PO, Rajanayagam O, Burris TP, Schwabe JW, Lazar MA, Chatterjee VK: A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J Biol Chem 275: 5754–5759, 2000.

    Article  PubMed  CAS  Google Scholar 

  91. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM: PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15: 351–357, 1995.

    PubMed  CAS  Google Scholar 

  92. Olswang Y, Cohen H, Papo O, Cassuto H, Croniger CM, Hakimi P, Tilghman SM, Hanson RW, Reshef L: A mutation in the peroxisome proliferator-activated receptor gamma-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc Natl Acad Sci USA 99: 625–630, 2002.

    Article  PubMed  CAS  Google Scholar 

  93. Walczak, R: Tontonoz P: PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. J Lipid Res 43: 177–186, 2002.

    PubMed  CAS  Google Scholar 

  94. Civitarese AE, Ukropcova B, Carling S, Hulver M, DeFronzo RA, Mandarino L, Ravussin E, Smith SR: Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab 4: 75–87, 2006.

    Article  PubMed  CAS  Google Scholar 

  95. Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, Moniwa N, Yoshida D, Shimamoto K: Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42: 76–81, 2003.

    Article  PubMed  CAS  Google Scholar 

  96. Kon KK, Quon MJ, Han SH, Chung WJ, Lee Y, Shin EK: Anti-inflammatory and metabolic effects of candesartan in hypertensive patients. Int J Cardiol 108: 96–100, 2005.

    Google Scholar 

  97. Watanabe S, Okura T, Kurata M, Irita J, Manabe S, Miyoshi K, Fukuoka T, Murakami K, Higaki J: The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension. Clin Ther 28: 1677–1685, 2006.

    Article  PubMed  CAS  Google Scholar 

  98. Hattori Y, Akimoto K, Gross SS, Hattori S, Kasai K: Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats. Diabetologia 48: 1066–1074, 2005.

    Article  PubMed  CAS  Google Scholar 

  99. Kurata A, Nishizawa H, Kihara S, Maeda N, Sonoda M, Okada T, Ohashi K, Hibuse T, Fujita K, Yasui A, Hiuge A, Kumada M, Kuriyama H, Shimomura I, Funahashi T: Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int 70: 1717–1724, 2006.

    Article  PubMed  CAS  Google Scholar 

  100. Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrie P: The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 63: 908–914, 2003.

    Article  PubMed  CAS  Google Scholar 

  101. Despres JP, Golay A, Sjostrom L: Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353: 2121–2134, 2005.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Medhavi Jogi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mandeep Bajaj
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Tulane University Health Sciences Center, New Orleans, LO, USA

    Vivian A. Fonseca (MD) (MD)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Jogi, M., Bajaj, M. (2009). Adiponectin and Cardiovascular Disease. In: Fonseca, V.A. (eds) Cardiovascular Endocrinology. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-141-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-141-3_10

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-850-8

  • Online ISBN: 978-1-59745-141-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation